小专论

γδT17细胞活化机制的研究进展

展开
  • (中国药科大学中药药理与中医药学系,南京 211198)

网络出版日期: 2023-04-27

基金资助

国家自然科学基金(82273939); 中国药科大学“双一流”建设项目(CPU2022QZ31)资助课题

Research Progress on the Mechanism of γδT17 Cell Activation

Expand
  • (Department of Pharmacology and Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China)

Online published: 2023-04-27

Supported by

 

摘要

IL-17是一种重要的促炎细胞因子,在炎症性疾病和自身免疫性疾病中发挥重要作用。研究发现,除Th17细胞外,γδT17细胞也是IL-17的重要来源。γδT17细胞参与多种免疫应答过程, 与感染性疾病、自身免疫性疾病和肿瘤等疾病的发生发展密切相关,本文综述γδT17细胞活化机制的研究进展,探明γδT17细胞的分化和活化机制将为上述疾病的治疗提供新思路。

本文引用格式

蔚晓晓 夏玉凤 戴 岳△ . γδT17细胞活化机制的研究进展[J]. 生理科学进展, 2023 , 54(2) : 130 -133 . DOI: 10.20059/j.cnki.pps.2023.02.1026

Abstract

IL-17 is an important pro-inflammatory cytokine, which has attracted widespread attention due to its crucial roles in inflammatory and autoimmune diseases. Studies have shown that in addition to Th17 cells, γδT17 cells are also vital sources of IL-17. γδT17 cells are intimately involved in multiple immune responses and closely associated with the occurrence and development of diverse diseases, such as infectious diseases, autoimmune diseases and tumors. This article summarizes the research advances in the mechanism of activation of γδT17 cells and elucidates the mechanism of the differentiation and activation of γδT17 cells, which is expected to provide new ideas for the treatment of the associated diseases.

参考文献

 
Options
文章导航

/